By Dr. Jack Wolfson DO, Cardiologist and Founder of Natural Heart Doctor
Does hormone replacement therapy protect your heart—or put it at risk?
When it comes to HRT and heart health, the answer depends on your age, when you start treatment, your medical history, and which hormones you use. HRT is an effective treatment for menopausal symptoms, but it is not recommended solely as a heart-disease strategy. For many otherwise healthy women younger than 60 or within 10 years of menopause, its benefits for bothersome symptoms can outweigh its risks. [1,2]
That does not mean every woman needs a prescription.
At Natural Heart Doctor, our preference is clear: the 100 Year Heart Method first. HRT last, not first, considered for troublesome symptoms that remain.
That is our clinical philosophy for typical menopause. Mainstream guidelines recognize HRT as an appropriate first-line option for significant symptoms. Women deserve to understand both the evidence and their choices.
Does HRT Help or Hurt Your Heart?
Hormone replacement therapy, also called menopausal hormone therapy, is not one uniform treatment. Estrogen pills, estradiol patches, combined estrogen-progestogen therapy, and low-dose vaginal estrogen have different uses and risk profiles.
HRT is the most effective treatment for hot flashes and night sweats. It also helps prevent bone loss and fractures while it is used. Those are meaningful benefits. They do not automatically establish that taking hormones will prevent a heart attack. [1]
For cardiovascular decisions, we need to ask:
- How old are you, and how long has it been since menopause?
- Do you already have cardiovascular disease or a history of blood clots?
- Are you considering oral estrogen or a treatment delivered through the skin?
- Do you need a progestogen because you still have your uterus?
- What symptoms or other medical indication are we treating?
A prescription should answer a specific need. Reaching menopause alone is not a reason to put every woman on hormones.

What Did the Women’s Health Initiative Find About HRT?
Much of the concern about HRT and heart disease came from the Women’s Health Initiative, or WHI.
The 2002 report studied 16,608 women assigned to oral conjugated equine estrogen plus medroxyprogesterone acetate or a placebo. Participants were 50 to 79 years old, and many were well beyond the menopause transition. [3]
For every 10,000 women treated for one year, the original report estimated:
| Outcome | Difference compared with placebo |
|---|---|
| Coronary heart disease events | 7 additional events |
| Stroke | 8 additional events |
| Pulmonary embolism | 8 additional events |
| Invasive breast cancer | 8 additional cases |
| Hip fracture | 5 fewer fractures |
| Colorectal cancer | 6 fewer cases |
These are absolute differences for the regimen and population studied. They are not a personalized risk estimate for a woman starting a different treatment today.
Later follow-up of both WHI hormone trials found no significant overall difference in all-cause, cardiovascular, or cancer mortality over 18 years. Participants received treatment for roughly five to seven years, not continuously for all 18 years. [4]
The research does not support treating all HRT as equally dangerous. It also does not establish hormones as a universal longevity treatment.
Does Starting HRT Before Age 60 Change Heart Risk?
Age matters. So does the time since menopause.
The benefit-risk balance is generally more favorable for otherwise healthy women younger than 60 or within 10 years of menopause who need treatment for bothersome symptoms and have no contraindications. Starting later generally carries greater absolute cardiovascular and clotting risks. [1]
A Cochrane review found lower relative risks of death and coronary heart disease in subgroup analyses of women who started hormone therapy within 10 years of menopause. Blood clot risk remained elevated. Across the overall trial population, hormone therapy offered little or no cardiovascular prevention benefit and increased stroke and venous clot risk. [5]
The ELITE randomized trial adds another piece of evidence. Estradiol slowed progression of carotid artery wall thickening when started within six years of menopause, but not when started 10 or more years later. That was an artery measurement—not proof of fewer heart attacks or longer life. [6]
Earlier initiation can change the balance of benefits and risks. It does not create a blanket recommendation for every woman to take HRT.
Are Estrogen Patches Safer Than HRT Pills?
For blood clots, the route of treatment matters. Oral estrogen increases venous clot risk; transdermal estrogen, delivered through a patch, gel, or spray, may carry a lower risk. A patch is not a guarantee of safety. [7]
The decision still depends on your history, dose, symptoms, and other medications.
Women with a uterus generally need a progestogen alongside systemic estrogen to protect the uterine lining. Low-dose vaginal estrogen is a different option for local vaginal and urinary symptoms; it is not a treatment for hot flashes. [7]
Are Bioidentical Hormones Safer for Your Heart?
“Bioidentical” describes hormones chemically identical to those made by the body. It does not mean risk-free.
FDA-approved bioidentical hormone products exist. Custom-compounded preparations are not automatically safer or more effective, and they can introduce concerns about dosing consistency and quality. [1]
Ask about the actual product, dose, route, and supporting evidence. The word on the label cannot replace an individualized assessment.
Who Should Avoid Systemic HRT?
Systemic HRT is generally unsuitable for women with a history of blood clots, stroke, heart attack or established coronary disease, certain hormone-sensitive cancers, unexplained vaginal bleeding, or liver disease. [1,7]
If you have one of these conditions, discuss symptom treatment with a clinician who understands that history. Low-dose vaginal treatment requires a separate assessment from systemic HRT.

Our Approach: The 100 Year Heart Method First
Our ancestors went through menopause without hormone prescriptions. That does not prove HRT has no value, but it reminds us that menopause is a normal life transition—not an automatic indication for medication.
Whenever possible, we want women to feel well without needing HRT.
Our 100 Year Heart Method asks a broader question: What is your body getting too much of, and what is it not getting enough of?
Too much ultra-processed food. Too little movement. Poor sleep. Chronic stress. Inadequate nourishment. Too little connection and support.
Normal ovarian aging is not a personal failure. But the health foundation around that transition deserves attention, whether you choose hormones or not.
Eat Well: Build Meals Around Real Food
Our approach emphasizes wild seafood, eggs, quality meats, vegetables, fruit, nuts, seeds, and other nutrient-dense foods you tolerate.
We look at adequate protein, fiber, and overall nourishment. We reduce ultra-processed foods and added sugar, and ask whether alcohol is disrupting sleep or triggering symptoms.
The goal is to nourish your body consistently—not leave you exhausted by another restrictive diet.
Live Well: Prioritize Movement and Sleep
Make room for daily movement, strength training, time outdoors, and a consistent sleep schedule. Get daylight during the day and keep your bedroom dark at night.
If sleep remains poor, investigate it. Night sweats may be part of the problem, but so can snoring, sleep apnea, alcohol, and a schedule that leaves no time to recover.
These habits belong in a heart-health plan. They are not guaranteed cures for hot flashes.
Think Well: Your Daily Life Deserves Attention
Are you overwhelmed? Isolated? Caring for everyone except yourself?
We want to understand your stress, relationships, support system, and opportunities to recover. Your symptoms matter. So does the life you are managing while experiencing them.
Test, Don’t Guess: Investigate Symptoms With a Purpose
Fatigue, poor sleep, and a racing or skipping heartbeat should not automatically be blamed on menopause.
Depending on your history, evaluation may include blood pressure, lipids, glucose or A1c, thyroid function, a blood count, or assessment for sleep apnea. Persistent palpitations may warrant rhythm monitoring.
Explore our heart-health testing options and discuss which tests answer a meaningful clinical question for you. A hormone number alone does not determine whether you need HRT, and broad testing is not a prerequisite for symptom relief.
Evidence-based supplements and biohacking strategies are targeted additions when appropriate. Our framework has not been proven in a head-to-head randomized trial to outperform HRT for menopause symptoms.

When Would We Consider Hormone Replacement Therapy?
If hot flashes, night sweats, or other menopause symptoms remain disruptive, HRT deserves an individualized discussion.
We consider the effect on your sleep and daily life, your age and time since menopause, your cardiovascular history, and the benefits and risks of the proposed treatment. We then reassess whether it is helping.
“HRT last, not first” does not mean making a woman suffer for months or requiring perfect lifestyle habits before receiving relief. Foundational care and symptom treatment can happen together. Nonhormonal treatments are also worth discussing when hormones are unsuitable or unwanted.
Premature ovarian insufficiency and early menopause—including early surgical menopause—require a different approach. Hormone therapy may be recommended even without troublesome symptoms because of the consequences of early estrogen loss, often until the usual age of natural menopause when no contraindication exists. Appropriate treatment should not be delayed by a lifestyle-only approach. [1,8]
HRT and Heart Health: Building Your Plan for Menopause
You deserve more than an automatic prescription—and more than being told to tolerate symptoms that are disrupting your life.
At Natural Heart Doctor, we start with the 100 Year Heart Method: Eat Well, Live Well, Think Well, purposeful testing, and targeted support. Then we assess what remains and whether treatment, including HRT, belongs in your plan.
Build health first. Make hormones a deliberate decision.
Want help deciding where to begin with your cardiovascular health during menopause? Schedule a Free Discovery Call with an NHD Coach to discuss your goals and which Natural Heart Doctor service may be appropriate for you. HRT prescribing decisions require an individual clinical evaluation.
Frequently Asked Questions
HRT is an effective treatment for menopausal symptoms, but it is not recommended solely as a heart-disease strategy. How it affects cardiovascular risk depends on your age, time since menopause, health history and the hormones used.
For many otherwise healthy women younger than 60 or within 10 years of menopause, the benefits for bothersome symptoms can outweigh the risks. Starting later generally carries greater absolute cardiovascular and clotting risks.
Oral estrogen increases venous clot risk, while transdermal estrogen delivered through a patch, gel or spray may carry a lower risk. A patch is still not a guarantee of safety.
Systemic HRT is generally unsuitable for women with a history of blood clots, stroke, heart attack or established coronary disease, certain hormone-sensitive cancers, unexplained vaginal bleeding or liver disease.
The 100 Year Heart Method first: Eat Well, Live Well, Think Well and purposeful testing. HRT is considered for troublesome symptoms that remain, and foundational care and symptom relief can happen together.
References
- The North American Menopause Society. The 2022 hormone therapy position statement.
- ACOG Committee Opinion No. 565: Hormone therapy and heart disease.
- Rossouw et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA, 2002.
- Manson et al. Menopausal hormone therapy and long-term all-cause and cause-specific mortality. JAMA, 2017.
- Boardman et al. Cochrane systematic review of hormone therapy and cardiovascular disease in post-menopausal women, 2015.
- Hodis et al. Vascular effects of early versus late postmenopausal treatment with estradiol. NEJM, 2016.
- The Menopause Society: Hormone Therapy.
- The Menopause Society: Premature Menopause.






